Alnylam Pharmaceuticals Inc logo

Alnylam Pharmaceuticals Inc

LTS:0HD2 (USA)   Ordinary Shares
$ 149.05 (-0.17%) May 20
At Loss
Market Cap:
$ 18.90B
Enterprise V:
$ 17.83B
Volume:
126.00
Avg Vol (2M):
263.00
Also Trade In:
Volume:
126.00
At Loss
Avg Vol (2M):
263.00

Alnylam Pharmaceuticals Inc Valuation Measures